Alyeska Investment Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-509,484
Closed -$555K 538
2023
Q3
$555K Sell
509,484
-1,232,868
-71% -$1.34M ﹤0.01% 424
2023
Q2
$3.99M Buy
+1,742,352
New +$3.99M 0.03% 340